Trial
NCT04655807
A Study of JNJ-64304500 as Add-on Therapy in Participants With Active Crohn's Disease
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Janssen Research & Development, LLC
Collaborators
—
Condition
Crohn Disease
Intervention
JNJ-64304500
Why stopped
Sponsor Decision.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-04-27